INGN
NASD Inogen, Inc.$6.42 ↑ +0.00 (+0.00%) Trading Up from the previous close of $6.42, $0.03 below the day’s high of $6.45
- YTD change
- -4.46%
- vs 20-day SMA
- +17.24%
- vs 200-day SMA
- +3.15%
Price ranges
Price & Performance
-0.03 (-0.47%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 97.8% away from all-time highs of $287.79
- INGN is down 4% since the beginning of the year
- INGN is down 21% over the past 12 months
- INGN is up 21% over the past 1 month
INGN reads very good: price sits above both the 20- and 200-day averages, the 12-month move is -20.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.01
- Last 5 days
- +7.54%
- vs 8-day SMA
- +9.58%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
